47 results on '"Kovan, Bilal"'
Search Results
2. The inferior performance of [68Ga]Ga-FAPI-04 PET/CT as a diagnostic and theranostic biomarker in [177Lu]Lu-DOTATATE refractory well-differentiated neuroendocrine tumors
3. The effects of kilovoltage (kV) and milliampere seconds (mAs) values for SPECT attenuation correction: An anthropomorphic phantom study
4. An international phantom study of inter-site variability in Technetium-99m image quantification: analyses from the TARGET radioembolization study
5. Determination of Optimum Imaging Numbers for 177Lu-PSMA Radionuclide Treatment Dosimetric Calculation
6. Influence of Early Versus Delayed Hepatic Artery Perfusion Scan on 90Y Selective Internal Radiation Therapy Planning.
7. Determination of Optimum Imaging Numbers for 177Lu-PSMA Radionuclide Treatment Dosimetric Calculation.
8. Influence of Early Versus Delayed Hepatic Artery Perfusion Scan on 90Y Selective Internal Radiation Therapy Planning
9. The inferior performance of [68Ga]Ga-FAPI-04 PET/CT as a diagnostic and theranostic biomarker in [177Lu]Lu-DOTATATE refractory well-differentiated neuroendocrine tumors
10. The effects of different kilovoltage (kV) and milliampere seconds (mAs) values for SPECT attenuation correction: An anthropomorphic phantom study
11. The inferior performance of [68Ga]Ga-FAPI-04 PET/CT as a diagnostic and theranostic biomarker in [177Lu]Lu-DOTATATE refractory well-differentiated neuroendocrine tumors.
12. Influencing factors of lung shunt fraction in transarterial radioembolization treatment
13. INVESTIGATION OF CENTERING PROBLEM IN THE CADMIUM ZINC TELLURIDE (CZT) CARDIAC CAMERA
14. A multi-institutional assessment of eye lens dose in nuclear medicine clinics
15. An anthropomorphic body phantom for the determination of calibration factor in radionuclide treatment dosimetry
16. Y90 selective internal radiation therapy and peptide receptor radionuclide therapy for the treatment of metastatic neuroendocrine tumors: combination or not?
17. Aim The endeavor was to measure the lens dose of actively working staff in nuclear medicine departments. Material and methods This study was accomplished in three nuclear medicine sites. A total of 23 workers in nuclear medicine joined this work. Among them are 6 SPECT/ CT technologists, 6 PET/CT technologists, 3 PET/ MRI technologists, 5 radiopharmacists, 2 physicists, and 1 physician. EXTDOSE Hp(3) OSL dosimeter with tissue equivalent beryllium-oxide crystal was used for lens dose measurement. All participants were asked to wear the lens dosimeter for 2 months as near to the eye level as possible. Results Pooling the dose measures together yielded an average lens dose of 1.48 ± 0.77 mSv for the radiopharmacy team, 1.44 ± 0.26 for PET/ CT technologists, 0.86 ± 0.45 mSv for SPECT/ CT technologists, 0.38 mSv for the sole physician administered 177Lu, and 0.45 ± 0.02 mSv for the physicists conducting 131I therapy. Moreover, normalizing the lens dose to the labeled activity led to a lens dose of 2.2 ± 1.4 µSv/GBq for the radiopharmacy team. Likewise, per administered activity: 23.8 ± 7.3 µSv/GBq for PET/CT and PET/MRI technologists, 12.2 ± 10.5 µSv/GBq 99mTc for SPECT/CT technologists, 6.0 ± 0.81 µSv/GBq 131I for physicists, and 3.0 µSv/GBq 177Lu for the physician. Conclusion It was deduced that the annual occupational lens dose of the nuclear medicine workers varied from 2.3 to 11.5 mSv/year; however, one radiopharmacist projected annual lens dose as close to the lens equivalent dose limit (20 mSv/year) as 17.9 mSv.
18. An Analysis for Therapeutic Doses of Patients with Neuroendocrine Tumor Treated with Lutetium-177-DOTATATE
19. Safety of Fibroblast Activation Protein–Targeted Radionuclide Therapy by a Low-Dose Dosimetric Approach Using 177Lu-FAPI04
20. An Analysis for Therapeutic Doses of Patients with Neuroendocrine Tumor Treated with Lutetium 177 (177Lu)-DOTATATE.
21. Radiation Safety Guide: General Definitions and Radiation Protection Rules in Nuclear Medicine Applications
22. Acceptance Tests and Quality Control of the Positron Emission Tomography (PET) Systems
23. Acceptance and Quality Control Tests for the Single Photon Emission Computerized Tomography (SPECT) Gamma Cameras and SPECT/CT Systems
24. A systematic quality assurance study in bone densitometry devices
25. Gamma radiation exposure of accompanying persons due to Lu-177 patients
26. Safety of Fibroblast Activation Protein-Targeted Radionuclide Therapy by a Low-Dose Dosimetric Approach Using 177Lu-FAPI04.
27. SPECT – BT ’nin Kalite Kontrolleri
28. Gama Kameraların Kalite Kontrol Testleri
29. Y90selective internal radiation therapy and peptide receptor radionuclide therapy for the treatment of metastatic neuroendocrine tumors: combination or not?
30. 177Lu ile nöroendokrin tümörlerinin tedavisinde radyasyon dozimetrisi
31. Radiation Safety Procedures For Non-Radiation Workers in Case of Application Radionuclide Therapy in the Dialysis Patients
32. Radiation Safety Process for the Patient and People Around during Diagnostic Radionuclide Studies
33. Medical Radiation Safety Process in Case of Changing Medical Condition of Patients Who Received Radionuclide Therapy or Radioactive Substances: Emergency Medical Procedures
34. Medical Radiation Safety Process in Case of Changing Medical Condition of Patients Who Received Radionuclide Therapy or Radioactive Substances: Emergency Medical Procedures
35. Radiation Safety Procedures For Non-Radiation Workers in Case of Application Radionuclide Therapy in the Dialysis Patients
36. Radiation Safety Process for the Patient and People Around during Diagnostic Radionuclide Studies
37. Quality Control Tests of SPECT- CT.
38. Nurse exposure doses resulted from bone scintigraphy patient
39. Nurse Exposure Doses Resulted From Bone Scintigraphy Patient.
40. Lobektomi Planlanan Hastada Kantitatif Akciğer Perfüzyon Sintigrafisine SPECT BT'nin Katkısı: Olgu Sunumu.
41. Nükleer Tıp'ta Görüntüleme Tekrarı Gerektiren Durumların Araştırılması.
42. Tc-99m-MAG3 Sintigrafisinde Tanımlanan Ekskresyon Fonksiyonunun Lu-177-PSMA Tedavisindeki Absorbe Böbrek Dozuyla İlişkisi.
43. Radyoembolizasyon Tedavi Planlamasinda Hepatik Arter Perfüzyon Görüntüleme Zamanının Dozimetrik Yaklaşıma Etkisi.
44. Transarterial Radioembolization With Yttrium-90 Microspheres for Treatment of Pediatric Hepatocellular Carcinoma.
45. SPE CT/BT Atenüasyon Düzeltmede kV, mAs Değerlerinin Araştırılması ve BT Dozları.
46. Influence of Early Versus Delayed Hepatic Artery Perfusion Scan on 90 Y Selective Internal Radiation Therapy Planning.
47. An Analysis for Therapeutic Doses of Patients with Neuroendocrine Tumor Treated with Lutetium 177 ( 177 Lu)-DOTATATE.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.